Publication | Closed Access
High-throughput metabolomics analysis discovers salivary biomarkers for predicting mild cognitive impairment and Alzheimer's disease
53
Citations
21
References
2016
Year
Metabolomic ProfilingMultiomicsNeurochemical BiomarkersAlzheimer's DiseaseBrain HealthNeurologyBiomarker DiscoveryAging-associated DiseaseHealth SciencesOmicsMild Cognitive ImpairmentMetabolomicsRisk FactorsNeurodegenerative DiseasesDementiaBiomarkersNeuroscienceMetabolic ProfilingMedicine
Mild cognitive impairment (MCI) confers an increased risk of developing Alzheimer's disease (AD).
| Year | Citations | |
|---|---|---|
Page 1
Page 1